



Title: Characteristic of slow growth in cell culture of adenovirus type 54 causing 1 
nationwide outbreak epidemic keratoconjunctivitis in Japan 2 
Running Title: Slow propagation of adenovirus 54 3 
Tomoko Tsukahara-Kawamura1,2), Nozomu Hanaoka2), Masami Konagaya2), Eiichi Uchio1) *, 4 
Tsuguto Fujimoto2) 5 
1) Department of Ophthalmology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, 6 
Jonan-ku, Fukuoka 814-0180, Japan 7 
2) Infectious Disease Surveillance Center, National Institute of Infectious Diseases, 1-23-1 8 
Toyama, Shinjuku-ku, Tokyo 162-8640, Japan 9 
*Corresponding author: Eiichi Uchio, M.D., PhD.  10 
Department of Ophthalmology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, 11 
Jonan-ku, Fukuoka 814-0180, Japan,  12 
Tel +81 92 801 1011 13 
Fax +81 92 865 4445 14 
E-mail: euchio@fukuoka-u.ac.jp 15 
Abstract 16 
Purpose: To characterize the virological features of adenovirus type 54 (Ad54) causing 17 




comparatively analysed the viral propagation phenotype of Ad54 and other Ads: Ad type 37 19 
(Ad37), 64 (Ad64), and 5 (Ad5), in A549 cells quantitatively. 20 
Study Design: Laboratory investigation  21 
Methods: We compared the growth rate of Ads using copy numbers and cytopathic effect 22 
observation during propagation in A549 cell lines. Expressions of mRNA of E1 gene were 23 
also calculated and compared. Phylogenetic analysis of the region, including putative 24 
promoter of E1 gene and E1 open reading frame (ORF), were performed.  25 
Results: Increases in viral loads, growth rate, and viral propagation were slower for Ad54 26 
than for other Ads. The expression level of the E1 gene per infected cell was lower for Ad54 27 
than for other Ad types on post-infection day 1. Phylogenetic analysis of the E1 gene putative 28 
promoter and ORF revealed Ad54 was the closest to Ad type 8. 29 
Conclusion: The propagation of Ad54 in A549 is slow compared with Ad37, Ad64 and Ad5. 30 
Slow propagation could have been caused by slow genomic replication resulting from 31 
delayed viral entry or E1 transcription initiation. The EKC caused by Ad54 needs more 32 
attention because the slow propagation of Ad54 may contribute to prolonged disease 33 
duration. 34 









Human mastadenovirus (Ad) is a DNA virus that infects various organs throughout the body 38 
[1]. Ad has a linear, double stranded DNA genome, approximately 35 kb in size [2]. Over 100 39 
types of Ad, including serotypes and genotypes, are known (http://hadvwg.gmu.edu/), and 40 
they belong to seven species (Ad A to G) [2].  41 
Among them, several members of Ad D species: Ad type 8 (Ad8), 37 (Ad37), 54 42 
(Ad54), and 64 (formerly known as 19a) (Ad64) are responsible primarily for causing 43 
epidemic keratoconjunctivitis (EKC). The ocular manifestations caused by the member of Ad 44 
D viruses are more severe than those caused by Ad B (Ad type 3, 7), C: Ad type 2, 5(Ad5), 45 
and E: (Ad type 4), which cause mild follicular conjunctivitis and pharyngoconjunctival fever 46 
[3]. Thus, typing Ad isolated from eye samples can predict the clinical course of the 47 
subsequent infection.  48 
 Recently, a number of recombinant Ad types have been identified and reported [4–49 
7], including Ad54, first reported as an Ad8 mutant in 2008 [8]. From 2015 to 2018, Ad54 50 
caused nationwide outbreak and was the most frequently detected Ad type in eyes of patients 51 
with EKC in Japan (https://nesid4g.mhlw.go.jp/Byogentai/Pdf/data41j.pdf),  furthermore, 52 
this type was found only in Japan until 2017 [9]. Globally, Ad8 is the main pathogen of EKC, 53 
whereas in Japan its detection has declined [10], where Ad54 has become the primary EKC 54 




high as that of Ad54 for 4 years consistently. Motivated by this epidemiological observation, 56 
we investigated the viral characteristics of Ad54.  57 
Species D reportedly exhibits slower reductions in the viral genome after infection [3] 58 
and the high viral loads of Ad54 in clinical samples were reported as maintained over a long 59 
period of time following disease onset [11]. As a feature of virus isolation from clinical 60 
samples, Akiyoshi, et al. [12], Nakamura, et al. [13], and Kaneko, et al. [14] report that Ad54 61 
detection is difficult and time-consuming. However, these three reports used only clinical 62 
samples which contained viral loads variously for virus isolation, while quantitative 63 
experiments could not be performed. Therefore, we conducted the quantitative analysis to 64 
make the same amount of viruses to inoculate in A549 cells and attempted to elucidate the 65 
reason for the difficulty of virus isolation with Ad54 compared with those of Ad37 and Ad64, 66 
the major forms of EKC in Japan, and used Ad5 as control.  67 
 68 
Materials and methods 69 
 70 
Viral strain and cell lines 71 
 72 
Prototype strains of Ad5 and Ad37 were obtained from the American Type Culture Collection 73 




Adenovirus Reference Center (the National Institute of Infectious Diseases; NIID) [15, 16]. 75 
The strains were grown in A549 cells (CCL-185, ATCC) with Minimum Essential Medium 76 
Eagle with Earle’s salts (Eagle’s MEM, Sigma-Aldrich Japan) supplemented with 5% fetal 77 
bovine serum (Biowest), 1% L-Alanine/L-Glutamine (200 mmol/L) (Wako Pure Chemical 78 
Industries (Wako)), 0.2% gentamicin sulfate solution (50 mg/ml) (Wako), and 0.1% 79 
amphotericin B (Wako) in 25 cm2 tissue culture flask (TPP. After a 100% cytopathic effects 80 
(CPE) was detected and subjected to two freeze-thaw cycles, the cells with medium were 81 
collected in a 15 mL conical centrifuge tube. The tube was centrifuged at 1,500 ×g for two 82 
minutes. The supernatant was collected in a new conical centrifuge tube, and 5% fetal bovine 83 
serum was added to make a total volume of 10 ml. Each 500 l of the supernatant was stored 84 
as viral stock at −80°C. All experiments described here were performed at NIID, an approved 85 
facility equipped for experiments with viral infections. This study was not subject to ethical 86 
review because it did not use clinical specimens or patient information. 87 
 88 
Observation of CPE  89 
 90 
A total of 50 μL of virus, containing 1.0 × 105 copies/μL, was inoculated into 24 wells of 91 
confluent A549 cell monolayers. The inoculated cells were maintained in 450 μL of 5% 92 




500 μL of 5% Eagle’s MEM to the control wells. The cultures were daily observed over 94 
seven days for the appearance of CPE. Each time the cells were observed, we took 95 
photographs using a phase-contrast microscope (Wraymer) to examine for CPE. Each 96 
experimental condition was analyzed using three wells. 97 
 98 
Measurement of the number of adenoviral genome copies  99 
After the virus was harvested, we collected cell pellets and supernatant from each well at 6 h, 100 
1, 2, 3, 4, 5, 6, and 7 days post-infection (dpi) (Fig. 1). First, 250 μL of the culture 101 
supernatant was sucked by a pipette into a 1.5-mL micro-centrifuge tube “A.” Tube A was 102 
centrifuged at 1,500×g for 5 minutes, and then 200 μL supernatant was collected into a new 103 
1.5 mL micro-centrifuge tube “B.” The cells that remained in the well were carefully scraped 104 
with a cell scraper (TPP) and collected into tube A. We poured 500 μL D-PBS (Wako) into 105 
the same well to wash the scraper and well, and then the wash solution was collected in tube 106 
A. Tube A was centrifuged at 1500×g for 5 minutes, and the supernatant was discarded. Tube 107 
A was preserved as a pellet tube and tube B as a supernatant tube at −80°C until DNA 108 
extraction.  109 
Before DNA extraction, tube A pellets were mixed well by vortexing with 200 μL D-110 
PBS. Tube B contents were used without any further processing. Viral DNA was extracted 111 




the extracted 100 μL of viral DNA at −80°C until PCR. The number of adenoviral genome 113 
copies per microliter of pellets was determined using quantitative real-time PCR (qPCR) 114 
following a previously described method [14] and the pharyngoconjunctival fever/EKC 115 
Diagnostic Manual, 3rd Edition (National Institute of Infectious Diseases, 116 
https://www.niid.go.jp/niid/images/lab-manual/adeno_v3.pdf). Briefly, 2 μL of template DNA 117 
was added to 18 μL in total containing 10 μL of 2× SYBR Premix Ex Taq II (Takara bio), 0.4 118 
μL of 50 × Rox Reference dye II (Takara bio), 0.16 μL of 50 μM concentration of the primers 119 
Hex 3 and Hex 4 (Supplemental Table), and 7.28 μL of DW. Real-time PCR was performed 120 
using the StepOne real-time PCR system (ABI) (StepOne). The cycling conditions included 121 
an initial denaturation step at 95°C for 1 min, followed by 40 cycles of denaturation at 95°C 122 
for 5 s, annealing, and extending at 60°C for 30 s. All experiments were repeated three times. 123 
 124 
Virus titration  125 
 126 
Ad virus titers were determined using micro titer plates by three-fold serial dilution of viral 127 
stock and inoculation with 100 μL of dilution into each of the 96 wells (TPP) containing a 128 
monolayer of A549 cells. Plates were incubated at 34°C with 5% CO2 and observed daily for 129 
CPE for seven days. The Spearman–Karber’s method was used to calculate the median tissue 130 





Calculation of Ads growth rate 133 
 134 
To compare the speed of viral propagation, growth rate was defined as the intracellular 135 
genomic gain of Ad, considered to represent genomic replication in the A549 cells before 136 
viral shedding into culture supernatant. The time point just before the virus was released into 137 
the supernatant was determined, and then, a straight line was drawn between two additional 138 
points: (1) the viral load at that point and (2) the viral load in pellets at 6 h. Specifically, we 139 
extracted viral loads in pellets at 6 h and 2 dpi for Ad5, 37, and 64 (Fig. 3A). For Ad54, viral 140 
loads in pellets were extracted at 6 h and on 3 dpi. Growth rate was calculated from the slope 141 
of the straight line as per the previous study [18]: Growth rate = Δ log viral load / Δ time. 142 
Statistical analyses (n = 3) were performed using one-way analysis of variance (ANOVA) 143 
followed by Tukey–Kramer post hoc test using Microsoft Excel 2011 (Microsoft) and 144 
Statcel4 add-in software (OMS). A p-value <0.05 was considered statistically significant. 145 
 146 
The expression levels of early transcription factor E1 gene per infected cell 147 
 148 
To synthesize cDNA, PrimeScript RT reagent Kit and gDNA Eraser Kit (Takara bio) were 149 




μL of total viral DNA from pellets, 2 μL of 5 × gDNA eraser buffer, and 1 μL of gDNA 151 
Eraser were mixed to form a total reaction volume of 10 μL. This solution was incubated at 152 
42°C for 2 min to eliminate the gDNA. Ten microliters of reverse-transcription reaction 153 
mixture, 4 μL of 5 × PrimeScript Buffer 2, 1 μL of PrimeScript RT Enzyme Mix 1, 1 μL of 154 
Oligo dT Primer (50uM) (Takara bio), and 4 μL of RNase Free dH2O were combined and 155 
incubated at 37°C for 15 min, followed by 85°C for 5 s, to generate cDNA using a PCR 156 
Thermal Cycler Dice (Takara bio). Eighty microliters of TE (pH 8.0) (Wako) were added to 157 
cDNA to make a total volume of 100 μL, stored at −20°C until use. The qPCR was performed 158 
using a StepOne and SYBR Premix Ex Taq II (Takara bio). Thermocycling was performed in 159 
a final volume of 20 μL containing 2 μL of the cDNA sample, 10 μL of 2 × SYBR Premix Ex 160 
Taq II, 0.4 μL of 50 × Rox Reference dye II, and 0.8 μL of 10 μM concentration of the each 161 
E1 primer (forward and reverse), and 6 μL of distilled water. The E1 primers for qPCR were 162 
designed by Primer Express Software v2.0 (ABI). All primers were checked for amplification 163 
efficiency, and only primers with equal amplification efficiencies were used in the 164 
experiments. PCR amplification was performed using a StepOne, and the cycling conditions 165 
were 95°C for 1 min and 40 cycles of 95°C for 5 s and 60°C for 30 s. To account for the 166 
number of infected cells per well, the RNase P gene (one copy of which is present in human 167 
genomic DNA) was quantified using the ABI TaqMan RNase P Detection Reagents Kit 168 




prepared using 10 μL of Probe qPCR Mix, 1 μL of 20 × RNase P Primer-Probe, 0.4 μL of 170 
Rox reference dye, 2 μL of viral DNA of pellets, and 6.6 μL of distilled water. Cycling 171 
conditions were 95°C for 20 s and 40 cycles of 95°C for 1 s and 60°C for 20 s. A series of 2 172 
serial dilutions of human genomic DNA containing the Kit was used in duplicate to produce 173 
the standard curve. The expression levels of E1 gene per infected cell were calculated 174 
according to the formula 2- (Ct)/ the number of cells, which were calculated from RNase P. 175 
Each experimental condition was analyzed in three wells and repeated three times. Statistical 176 
analyses were performed using ANOVA followed by Tukey–Kramer post hoc test using 177 
Microsoft Excel 2011 with Statcel4 add-in software. A p-value of <0.05 was considered 178 
statistically significant. 179 
 180 
Phylogenetic analysis of the region including promoter of E1 gene and E1 open reading 181 
frame (ORF) 182 
 183 
To investigate growth rate delays and E1 expression in Ad54, we compared the E1 upstream 184 
sequence, including putative E1 promoter and regulator, and ORF of E1 in Ad related to EKC 185 
and Ad5. The genome sequences of Ad5 (AY339865.1), Ad37 (AB448775.1), Ad54 186 
(AB333801.2), Ad64 (JQ326307.1), Ad type 8 (Ad8: AB448767.1), and Ad type 56 (Ad56: 187 




//www.ncbi.nlm.nih.gov/nuccore.). The multiple alignments and phylogenetic tree analysis 189 
were performed using MEGA 6.0 software (https://www.megasoftware.net/). DNA sequences 190 
were aligned using the ClustalW program (http://www.ebi.ac.uk/clustalw/) with an open gap 191 
penalty of 15, a gap extension penalty of 6.66, a transition weight of 0.5 with IUB DNA 192 
weight matrix, and a delay divergent cutoff of 30%. The neighbor-joining method was used 193 
for phylogenetic tree analysis, the reliability of which was assessed by bootstrap resampling 194 
(1,000 pseudo-replicates). Kimura’s 2-parameter method was used to calculate genetic 195 




Viral replication comparisons 200 
 201 
CPE  202 
Fig. 2 depicts CPE induced by Ads. Each of the A549 cells infected with Ad5, 37, and 64 203 
became enlarged, rounded, and were highly refractile on the third dpi. By 4 dpi, they 204 
aggregated into irregular clusters on the well plate bottoms (Fig. 2). A day later, all the cells 205 
dispersed from the well plate bottoms and were observed floating in the culture medium. The 206 




and 64 cells all floated within 24 h, and Ad54 floated within 48 h. Compared to the other 208 
types, Ad54 required more dpi (time) for confirmation of CPE. No CPE was observed in the 209 
negative control.  210 
Comparisons of viral loads of Ad genomic DNAs and TCID50  211 
We separately compared the viral loads of Ad genomic DNAs in pellets of A549 cells and 212 
supernatant. On 1 dpi, Ad5, 37, and 64 copies increased in the pellets by ~100-fold. The viral 213 
copies of these three Ads reached ~10,000-fold (maximum) from initial viral loads within 3 214 
dpi (Fig. 3A). On 2 dpi, Ad5, 37, and 64 exhibited viral shedding into the culture supernatant 215 
(Fig. 3B). On 2 dpi, the Ad54 viral load in cultured cells reached was ~100-fold of 216 
inoculation levels and reached ~10,000-fold of inoculation levels on 6 dpi; however, the 217 
levels failed to plateau (maximum) within 7 days. Clear virus shedding into the supernatant 218 
was observed on 3 dpi. Compared to the cells infected with other Ads, the viral loading of 219 
Ad54 was slower both in the pellets and in supernatant. Table 1 shows the relationships 220 
between the viral loads of Ad genomic DNA and TCID50. TCID50 had the lowest viral loads 221 
in Ad54.  222 
Comparison of Ad growth 223 
Intracellular genomic gains occurred on 2 dpi for Ad5, 37, and 64 and on 3 dpi for Ad54 (Fig. 224 
3B). The growth rates displayed in Table 2 were calculated using the formula shown in the 225 




other D types (p < 0.01). No significant differences were found between Ad37 and Ad64. The 227 
growth rate of Ad54 was significantly lower than those of other types. 228 
 229 
Confirmation of E1 gene expression (Fig. 4) 230 
 231 
Relative expression levels of the Ad54 E1 gene were significantly lower than cells infected 232 
with other Ads on 1 dpi and gradually increased on 2 dpi and 3 dpi.  233 
 234 
Phylogenetic analysis of the E1 gene putative promoter and ORF 235 
 236 
DNA sequences of types Ad37 and 64 were phylogenetically closest for both the putative 237 
promoter and ORF of the E1 gene. Ad54 was the closest to Ad8. Ad5 was the 238 
phylogenetically farthest from Ad54 (Figs. 5A, B). 239 
 240 
Discussion 241 
There are no comparative reports with accurate quantification on the propagation of Ad54 , 242 
therefore, we compared the phenotypic proliferative properties of Ad37, 54, and 64, which 243 
are the major causes of EKC in Japan. Although Ad8 is a major EKC pathogen globally, it 244 




strain of Ad8 provided by ATCC was contaminated with Ad type 10 [20] and (2) Ad8 strains 246 
may have differences in their propagation speeds among strains [21–23]. The hypothesis 247 
about Ad8 strains should be clarified in another paper. To date, no differences in viral 248 
propagation among strains, such as Ad8, have been observed in Ad54. A549 was used as the 249 
most sensitive cells to isolate Ads, including Ad54 [12, 24, 25]. We inoculated the same 250 
amount of each Ad virus at the beginning and separately compared Ad viral loads in pellets 251 
with supernatant, the latter was assumed to contain the complete Ad virions [26]. 252 
Our results produced five major characteristics of Ad54. First, the initiation of CPE 253 
and the time required until all the cells show CPE in Ad54 were delayed compared with other 254 
Ads (Fig. 2). Second, viral load in pellets and viral shedding in supernatant were slower for 255 
Ad54 than for the other types (Figs. 3 a, b, c). Third, the growth rate of Ad54, indicated by 256 
intracellular genomic gain, was significantly slower than the other types (Table 2). Fourth, the 257 
relationship between Ad54 genomic DNA viral loads and TCID50 was the lowest among the 258 
tested types (Table 1). Last, Ad54 was the lowest level on 1 dpi, according to the expression 259 
level of the E1 gene per infected cell, which acts as an indirect measure of viral entry (Fig. 4). 260 
Slower viral propagation of Ad54 could be (at least partly) due to slow E1 261 
expression or slowing of the steps that precede E1 expression. In other words, Ad54 could 262 
experience defects during any of the early steps of viral replication: virus adsorption, entry, or 263 




from the pellet at 6 h after infection, the virus may have been able to adsorb to the host cells. 265 
Notably, there was some lag between viral entry and E1 gene transcription initiation in Ad54. 266 
We were unable to prove the existence of any defects in viral entry of Ad54. However, 267 
assuming no viral entry issues, the delayed E1 gene transcription initiation might have 268 
resulted from an E1 gene putative promoter or the ORF of the E1 gene itself. 269 
E1 gene expression is directly linked to the growth rate. Therefore, we investigated 270 
phylogenetic differences among the Ad viruses for E1 gene promotion. Four complete 271 
sequences of Ad54 (AB333801, LC215446, LC215427, and LC215423) were obtained from 272 
the NCBI database. The upstream region of E1 and E1 ORF were identical among the strains. 273 
The putative promoter and ORF of the Ad54 E1 gene were phylogenetically closest to Ad8 274 
(Fig. 5). Ad54 is considered phylogenetically derived from Ad8 [28, 29]. We could not 275 
investigate Ad8 in this study; however, the growth rate of Ad8 may be slow [21, 23]. This 276 
prediction is consistent with the results of previous reports, in which Ad8 could not be 277 
isolated from clinical samples [13, 14].  278 
Our results indicate that the slow propagation of Ad54 could have been caused by 279 
slow genomic replication resulting from delayed viral entry or E1 transcription initiation that 280 
induced an overall delay in genome replication. Slow propagation might be the reason owing 281 




Because viral replication in Ad54 was delayed, the latent period may be longer than 283 
the typical 8–10 days [30]. Additionally, slow propagation of Ad54 might have prolonged the 284 
duration of infection. Furthermore, species D reportedly exhibits slower reductions in the 285 
viral genome after infection [2]. Therefore, Ad54 appeared to take long from latency to 286 
termination of infection than the other types. Extended duration of the disease can lead to an 287 
increase in the chance of infecting others, likely spreading the infection. There is currently no 288 
effective treatment for EKC, and when nosocomial infections or a major epidemic occur, the 289 
resultant social and economic losses can be substantial [31, 32].  290 
Limitation of this study: we used only A549 cells, believed to be the most sensitive 291 
cell line for Ads. To verify whether these experimental results can be applied to conjunctival 292 
epithelial cells in vitro and in vivo, additional quantitative experiments are required in the 293 
future. The experiment for the viral propagation should be performed in the near future for 294 
other EKC types of Ad, including prototype Ad8 and recent isolates, such as Ad8, Ad53, 295 
Ad56, etc. Because expression level analysis and cell observation imaging were not 296 
conducted by sorting only infected cells, the correlation between the expression level of E1 297 
and CPE after the virus entered the cell could not be proved in this study. Infection 298 
experiments after cell synchronization will be necessary in the future. 299 
The slower propagation of Ad54 compared to the other Ads was confirmed kinetically 300 




countermeasures for each Ad type. Ads are highly contagious and considering that high viral 302 
loads are maintained at infection onset [11], more attention is required to prevent the spread 303 
of Ad54. 304 
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 403 
Figure legends 404 
 405 
Fig. 1 Methods of collecting cell pellets and supernatant. First, 250 μL of the culture 406 
supernatant was sucked by a pipette into a 1.5 mL micro-centrifuge tube A. A was centrifuged 407 
at 1,500×g for 5 minutes, and then 200 μL supernatant was collected into a new 1.5 mL 408 
micro-centrifuge tube B. The cells that remained in the well were carefully scraped with a 409 
cell scraper and collected in tube A. We poured 500 μL D-PBS into the same well to wash the 410 
scraper and well, and then the wash solution was collected in tube A. Tube A was centrifuged 411 
at 1500×g for 5 minutes, and the supernatant was discarded. Tube A was preserved as a pellet 412 





Fig. 2 Cytopathic effects (CPE) of Human mastadenoviruses (Ads) on each day post-415 
infection (dpi). CPEs induced by Ad5, 37, 64, and 54 were photographed using a phase-416 
contrast microscope on 3, 4, 5, and 6 dpi (original magnification, ×200). The cells became 417 
enlarged, rounded, and highly refractile in the early stages of CPE. After that, they aggregated 418 
into irregular clusters, gathering on the bottoms of well plates (arrows) on 3 dpi for Ad5, 37, 419 
and 64. On the other hand, in Ad54, the cell began to swell on 4 dpi, and the clear CPE was 420 
recognized on 5 dpi. All the cells floated within 24 h for HAdV5, 37, and 64. Ad 54 required 421 
48 h to develop the same kind of microscopic features. The initiation of CPE and the time 422 
required until all the cells were impacted by CPE in Ad54 were delayed compared with the 423 
other Ads. CPE was not observed in the negative control. N, negative control; Ad, Human 424 
mastadenovirus; dpi, Days post-infection. Scale bar: 50 µm 425 
 426 
Fig. 3 The amount of Ads DNA copies and growth rate. The amount of Ads DNA copies in 427 
pellets (a), supernatant (b), and total (c) per well post-infection. The viral copies increased 428 
~10,000-fold (maximum) within 3 dpi (a). Viral shedding of Ad5, 37, and 64 into the culture 429 
supernatant was observed on 2 dpi (b). On the other hand, the viral load of Ad54 in pellets 430 
reached ~100-fold of the inoculation levels on 2 dpi, reaching ~10,000-fold by 6 dpi. Ad54 431 




triplicate assays at each time point are indicated by error bars. Abbreviations; Ad, Human 433 
mastadenovirus; Dpi, Days post-infection. 434 
 435 
Fig. 4 The E1 gene expression level. mRNA of E1 gene serves as an indirect measure of viral 436 
entry for each Human mastadenovirus type 5 (Ad5), 37 (Ad37), 54 (Ad54), 64 (Ad64), and 437 
negative control (N), as detected by quantitative real-time PCR on 1, 2, and 3 dpi. The 438 
relative E1 gene expression level for Ad54 was significantly lower compared with that of the 439 
other Ads on 1 dpi and gradually increased on 2 and 3 dpi. The standard deviations for each 440 
time point of the triplicate assays are indicated by error bars. *Significant differences (p < 441 
0.05) between Ad54 and all the other Ads by one-way ANOVA followed by the Tukey–442 
Kramer post hoc test. Abbreviations: Ad, Human mastadenovirus; N, negative control; N.D., 443 
not detected; Dpi, Days post-infection 444 
 445 
Fig. 5 Delayed E1 gene transcription initiation Phylogenetic analysis of the E1 upstream 446 
region and E1 open reading frame (ORF) 447 
Phylogenetic tree of (a) the upstream region, including the E1 putative promoter and 448 
regulator and (b) E1 gene among Ads related to EKC. Types Ad37 and 64 were the closest 449 




phylogenetically, the farthest from Ad54. The scale bar shows the number of base 451 
substitutions per site.  452 
* The length of upstream region is as follows: Ad5:559bp, Ad8:563bp, Ad37:569bp, 453 
Ad54:568bp, Ad56:571bp, and Ad64:569bp. 454 
# The Ad5 E1 ORF includes several introns and region from 560 to 1545 in AY339865.1. 455 
(986bp). The Ad8 E1: ORF includes several introns and region from 564 to 1420 in 456 
AY339865.1. (857bp). The Ad37 E1: ORF includes several introns and region from 570 to 457 
1426 in AB448775.1. (857bp). The Ad54 E1: ORF includes several introns and region from 458 
569 to 1425 in AB333801.2. (857bp). The Ad56 E1: ORF includes several introns and region 459 
from 572 to 1422 in HM770721.2. (851bp). The Ad64 E1: ORF includes several introns and 460 












Table 1 The relationship between viral loads of Ad genomic DNAs and TCID50  470 
Ad type TCID50 /ml at 105 copies / μL Ratio of TCID50 /ml at 105 copies / μL* 
Ad5 1.54 × 105 12 
Ad37 1.87 × 105 14 
Ad54 1.31 × 104 1 
Ad64 3.43 × 104 3 
Abbreviations: Ad, Human mastadenovirus; TCID50, the median tissue culture infective dose.  
*The ratio of TCID50/ml was calculated by setting the TCID50/ml value at 105 copies/μL of Ad54 to 1. 
 471 




Table 2 Growth rate of each Ads  473 
Ad5 Ad37 Ad54 Ad64 
0.11* 0.09* 0.05 0.09* 
Abbreviations: Ad, Human mastadenovirus. 
*Significant differences (p < 0.05) between Ad54 and all the other Ads by one-way ANOVA followed 
































Supplemental Table. The primers used in this study. 
 
Primer name Nucleotide sequence (5'–3') Target region Reference 
Hex3 GACATGACTTTCGAGGTCGATCCCATGGA Ad5, 37, 64 hexon 3 
Fujimoto T, et al.15 
Hex4 CCGGCTGAGAAGGGTGTGCGCAGGTA Ad5, 37, 64 hexon 4 
Hex3-Ad54 GACATGACCTTTGAGGTGGACCCCATGGA Ad54 hexon 3 
Hex4-Ad54 CCGGCGGAGAAGGGCGTGCGCAGGTA Ad54 hexon 4 
Ad5_E1F CCAACGAGGAGGCGGTTT  
Ad5 E1 This study 
Ad5_E1R  TCCTGCACCGCCAACAT 
Ad54_E1_F AATGACACGCCCCTGCAA 
Ad54 E1 This study 
Ad54_E1_R TCTCGCCACTCGGTCTAACC 
Ad37, 64_E1_F CCGGGCAAGGCTGTAGATC 
Ad37, 64 E1 This study 
Ad37, 64_E1_R GCGTTTGTGTCTCCGGTCTT 
Ad, human mastadenovirus   
 
